Cargando…

The Role of PARP1 in Monocyte and Macrophage Commitment and Specification: Future Perspectives and Limitations for the Treatment of Monocyte and Macrophage Relevant Diseases with PARP Inhibitors

Modulation of PARP1 expression, changes in its enzymatic activity, post-translational modifications, and inflammasome-dependent cleavage play an important role in the development of monocytes and numerous subtypes of highly specialized macrophages. Transcription of PARP1 is governed by the prolifera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sobczak, Maciej, Zyma, Marharyta, Robaszkiewicz, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565932/ https://www.ncbi.nlm.nih.gov/pubmed/32900001 http://dx.doi.org/10.3390/cells9092040

Ejemplares similares

PARP Traps Rescue the Pro-Inflammatory Response of Human Macrophages in the In Vitro Model of LPS-Induced Tolerance
por: Pietrzak, Julita, et al.
Publicado: (2021)

PARP1 Co-Regulates EP300–BRG1-Dependent Transcription of Genes Involved in Breast Cancer Cell Proliferation and DNA Repair
por: Sobczak, Maciej, et al.
Publicado: (2019)

Downregulation of PARP1 transcription by promoter-associated E2F4-RBL2-HDAC1-BRM complex contributes to repression of pluripotency stem cell factors in human monocytes
por: Wiśnik, Ewelina, et al.
Publicado: (2017)

Advances and perspectives of PARP inhibitors
por: Yi, Ming, et al.
Publicado: (2019)

Author Correction: Downregulation of PARP1 transcription by promoter-associated E2F4-RBL2-HDAC1-BRM complex contributes to repression of pluripotency stem cell factors in human monocytes
por: Wiśnik, Ewelina, et al.
Publicado: (2018)

Genetics of SLE: Functional Relevance for Monocytes/Macrophages in Disease
por: Byrne, Jennifer C., et al.
Publicado: (2012)

PARP Inhibitors Resistance: Mechanisms and Perspectives
por: Giudice, Elena, et al.
Publicado: (2022)

PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation
por: Iwata, Hiroshi, et al.
Publicado: (2016)

PARP inhibitors
por: Anwar, Maheen, et al.
Publicado: (2015)

The Ubiquitin Ligase TRIP12 Limits PARP1 Trapping and Constrains PARP Inhibitor Efficiency
por: Gatti, Marco, et al.
Publicado: (2020)

Monocyte and macrophage reactions.
por: Douglas, S D
Publicado: (1974)

Transglutaminases in Monocytes and Macrophages
por: Sun, Huifang, et al.
Publicado: (2018)

PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling
por: van Beek, Lotte, et al.
Publicado: (2021)

Plasminogen activator-specific inhibitors produced by human monocytes/macrophages
Publicado: (1987)

Perspectives on PARP Inhibitor Combinations for Ovarian Cancer
por: Bonadio, Renata Colombo, et al.
Publicado: (2021)

PARP-inhibition reprograms macrophages toward an anti-tumor phenotype
por: Wang, Lin, et al.
Publicado: (2022)

PARPs and ADP-Ribosylation in Chronic Inflammation: A Focus on Macrophages
por: Santinelli-Pestana, Diego V., et al.
Publicado: (2023)

PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs
por: Wang, Luyao, et al.
Publicado: (2017)

Interactions of PARP1 Inhibitors with PARP1-Nucleosome Complexes
por: Maluchenko, Natalya, et al.
Publicado: (2022)

Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical trials involving PARP inhibitors
por: Marques, Maud, et al.
Publicado: (2015)

PARP inhibitors: the race is on
por: Brown, Jessica S, et al.
Publicado: (2016)

PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites
por: Lin, Xiaohui, et al.
Publicado: (2022)

PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
por: Rose, Maddison, et al.
Publicado: (2020)

PARP1 promoter links cell cycle progression with adaptation to oxidative environment
por: Pietrzak, Julita, et al.
Publicado: (2018)

The monocyte-macrophage axis in the intestine
por: Bain, Calum C., et al.
Publicado: (2014)

Population of Monocyte-Derived Macrophages
por: McGovern, Naomi, et al.
Publicado: (2015)

Monocyte and macrophage immunometabolism in atherosclerosis
por: Groh, Laszlo, et al.
Publicado: (2017)

The HIV Reservoir in Monocytes and Macrophages
por: Wong, Michelle E., et al.
Publicado: (2019)

Monocytes and Macrophages in COVID-19
por: Knoll, Rainer, et al.
Publicado: (2021)

Monocyte and Macrophage Function Diversity
por: Kloc, Malgorzata, et al.
Publicado: (2022)

The Roles of Monocyte and Monocyte-Derived Macrophages in Common Brain Disorders
por: Zhao, Mingxia, et al.
Publicado: (2020)

Clinical PARP inhibitors allosterically induce PARP2 retention on DNA
por: Langelier, Marie-France, et al.
Publicado: (2023)

LSD1 Facilitates Pro-Inflammatory Polarization of Macrophages by Repressing Catalase
por: Sobczak, Maciej, et al.
Publicado: (2021)

PARP Inhibitors: Clinical Limitations and Recent Attempts to Overcome Them
por: Kim, Dongha, et al.
Publicado: (2022)

PARP Inhibitors in Endometrial Cancer: Current Status and Perspectives
por: Musacchio, Lucia, et al.
Publicado: (2020)

A decade of clinical development of PARP inhibitors in perspective
por: Mateo, J, et al.
Publicado: (2019)

Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers
por: Parisi, Alessandro, et al.
Publicado: (2023)

Serine-linked PARP1 auto-modification controls PARP inhibitor response
por: Prokhorova, Evgeniia, et al.
Publicado: (2021)

Counteracting Akt Activation by HIV Protease Inhibitors in Monocytes/Macrophages
por: Pasquereau, Sébastien, et al.
Publicado: (2018)

PARP inhibitors are not all equal
por: Dent, Paul
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l10g37haac7fl9j5i12n7eogv8